Kimberly-Clark Lags Behind Peers as China Disruption Takes Toll
Kimberly-Clark's stock performance has been underwhelming compared to other consumer defensive stocks. With a market cap of $34.2 billion, the Dallas-based company is a large-cap stock that operates in two main segments: North America and International Personal Care.
The company offers products such as diapers, baby wipes, feminine and incontinence care items, and tissue products under brands like Huggies, Kleenex, Kotex, and Scott. It sells its products to retailers, distributors, businesses, and e-commerce channels worldwide.
Shares of Kimberly-Clark have pulled back 23.1% from its 52-week high of $130.83. The stock has fallen marginally over the past three months, in line with the broader State Street Consumer Staples Select Sector SPDR ETF's (XLP) performance over the same period.
Kimberly-Clark reported Q2 2026 results on Aug. 4, with fiscal 2026 adjusted EPS attributable to Kimberly-Clark expected to decline at a low-single-digit rate on a constant-currency basis and organic sales growth is projected to be about 100 basis points below its weighted-average category growth of roughly 2%.
The outlook was pressured by China's diaper-market disruption, which reduced Q2 organic sales growth by about 50 basis points and is expected to have a further near-term impact on sales and profits, alongside business exits and higher brand and supply-chain investments. In comparison, rival The Procter & Gamble Company (PG) has outpaced KMB stock.
Despite Kimberly-Clark's weak performance relative to its peers, analysts are moderately optimistic about its prospects. The stock has a consensus rating of 'Moderate Buy' from the 16 analysts covering it, and the mean price target of $117.18 is a premium of 13.8% to current levels.